Form 4 for GH Guardant Health, Inc.
Accepted 2025-01-02 00:00:00 ET · period of report 2024-12-31 · accession 0001576280-25-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-02 | 2024-12-31 | GH | Krognes Steve E. | Dir | M - OptEx | $0.00 | +155 | 10.2K | +2% | $0 |
| D | 2025-01-02 | 2024-12-31 | GH | Krognes Steve E. | Dir | M - OptEx | $0.00 | -155 | 2,777 | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-31 | M | A | 155 | $0.00 | 10,220 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2024-12-31 | M | D | 155 | $0.00 | 2,777 | D | $0.00 · — to — | 155 Common Stock | (F1) This represents a restricted stock unit award granted on August 9, 2022 that vested as to 25% of the shares subject to such award on June 30, 2023, and as to the remaining 75% of the shares subject to such award vests in substantially equal installments on each monthly anniversary of June 30, 2023, during the three-year period thereafter. (F2) Not applicable for Restricted Stock Units. |